
Jason P Moran MD
Hematologic Oncology, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology
Hematologist/Oncologist, Maine Medical Center
Join to view full profile
265 Western Ave Suite 2South Portland, ME 04106
Phone+1 207-661-0200
Fax+1 888-368-4071
Dr. Moran is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2019
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2015
Massachusetts General HospitalInternship, Transitional Year, 2011 - 2012
Georgetown University School of MedicineClass of 2011
Certifications & Licensure
ME State Medical License 2019 - 2027
MA State Medical License 2016 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 24 citationsManaging thromboembolic risk in patients with hereditary and acquired thrombophiliasJason P. Moran, Kenneth A. Bauer
Blood. 2020-01-30 - 17 citationsDe novo ALK kinase domain mutations are uncommon in kinase inhibitor-naïve ALK rearranged lung cancersAntonio R. Lucena-Araujo, Jason P. Moran, Paul A. VanderLaan, Dora Dias-Santagata, Erik Folch
Lung Cancer. 2016-09-01 - 29 citationsPulse Afatinib for ERBB2 Exon 20 Insertion–Mutated Lung AdenocarcinomasDaniel B. Costa, Susan E. Jorge, Jason P. Moran, Jason A. Freed, Jessica A. Zerillo
Journal of Thoracic Oncology. 2016-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









